Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury-Reference-Cited by-同舟云学术

Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury

Published:2007-01 Issue:1 Volume:1774 Page:5-15
ISSN:1570-9639
Container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics

Author:

Buerke Michael,Guckenbiehl Markus,Schwertz Hansjörg,Buerke Ute,Hilker Michael,Platsch Herbert,Richert Joachim,Bomm Sabine,Zimmerman Guy A.,Lindemann Stephan,Mueller-Werdan Ursula,Werdan Karl,Darius Harald,Weyrich Andrew S.

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics,Analytical Chemistry

Reference42 articles.

1. The three processes leading to post PTCA restenosis: dependence on the lesion substrate;Fuster;Thromb. Haemost.,1995

2. Percutaneous transluminal coronary angioplasty;Landau;N. Engl. J. Med.,1994

3. The emerging concept of vascular remodeling;Gibbons;N. Engl. J. Med.,1994

4. Elastin is an essential determinant of arterial morphogenesis;Li;Nature,1998

5. Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model;Tai;Arterioscler. Thromb. Vasc. Biol.,2000

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress on developing an effective below-the-knee drug-coated balloon;Reviews in Cardiovascular Medicine;2021

2. Combinatorial therapy of sirolimus and heparin by nanocarrier inhibits restenosis after balloon angioplasty ex vivo;Nanomedicine;2020-05

3. Adventitial injection delivery of nano-encapsulated sirolimus (Nanolimus) to injury-induced porcine femoral vessels to reduce luminal restenosis;Journal of Controlled Release;2020-03

4. Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting;PLOS ONE;2018-06-11

5. Pharmacokinetic Study of Sirolimus-Eluting BioResorbable Vascular Scaffold System for Treatment of De Novo Native Coronary Lesions: A Sub-Study of MeRes-1 Trial;Cardiology Research;2018